Post by @ducky@mstdn.ca

2026-10-18 18:41 UTC

@Meow@corneill.es I am not a doctor, but I have a section on my website with a collection of research pertaining to treatments which seem to reduce Long COVID. https://covidbc.webfoot.com/therapies/#prevention Some are medicines (e.g. metformin, SSRIs, Xocova), so difficult to get. The easiest ones are vitamin B3 and antihistamines (and of course getting vaccinated). The B3 results are from exactly one paper. There are only two papers about antihistamines and Long COVID, but are is quite a bit of research supporting the use of antihistamines in COVID treatment. My doctor told me to be verrry careful with neomycin (which @Rhyothemis@zeroes.ca linked to) There are some bad side effects.

Replies (2)

@Rhyothemis@zeroes.ca 2026-10-18 18:45

@ducky@mstdn.ca @Meow@corneill.es The primary adverse event associated with topical neomycin is allergic contact dermatitis - patch test first. I'm 'allergic to everything' (corn allergy, MCAS) & have eczema and I don't react to it. https://pmc.ncbi.nlm.nih.gov/articles/PMC12134448/ "The pooled prevalence of CA [contact allergy] to neomycin was found to be 3.2% (95% confidence interval [CI]: 2.6%–3.8%) in adults and 4.3% (95% CI: 2.65%–6.3%) in children. The highest prevalences were observed in North America (adults: 6.4%; children: 8.1%) and South Asia (adults: 4.9%), while Europe showed lower rates (adults: 2.5%; children: 0.8%). Studies after the year 2000 indicated a prevalence of 2.1% in adults and 5.1% in children across geographical regions. "

Open ##5174039
@Meow@corneill.es 2026-10-18 21:19

@ducky@mstdn.ca Your entire website looks very interesting so thank you for that as well Antihistamines makes me wonder whether your " base level " of airborne allergies influences covid severity

Open ##5174041